IPO Premiums
IPO calendar
SLListed

Sai Life Sciences Limited

Bookbuilding IPO · NSE, BSE

Price band
₹522 - ₹549
Lot size
27 shares
Issue amount
₹3,042.62 cr
Total subscription
10.27×
Current price₹1,395.9
Listing price ₹650
Watch live price ↗
Opens
11 Dec 2024
Closes
13 Dec 2024
Allotment
16 Dec 2024
Listing
18 Dec 2024

Offer at a glance

Issue overview

Issue size
5,54,21,123 shares
Face value
₹1 Per Share
Minimum investment
₹14,094
Fresh issue
₹950 cr
Offer for sale
₹2,092.62 cr
Registrar
Kfin Technologies Limited
Listing exchange
NSE, BSE
Maximum investment
₹14,823
Issue type
Bookbuilding IPO
Shares before issue
19,06,85,340
Shares after issue
20,79,89,529

Lot sizes

CategoryLotsSharesAmount
Retail127₹14,823
sHNI14378₹2,07,522
bHNI681,836₹10,07,964

Share reservation

QIB28.57%
HNI21.43%
RETAIL50%

Subscription & GMP

Subscription by category

Total subscribed10.27×

Missing multiples are calculated from bids and offered shares when available.

QIB29.78×
NIB4.99×
HNIs(10L +)6.1×
HNIs (2-10L)2.78×
RETAIL1.39×

GMP history

035.57120 May: ₹71
20 May₹7120 May

Application-wise demand

CategoryReserved applicationsApplied applications
RETAIL7,18,4229,96,756
HNIs(10L +)14,66289,454
HNIs (2-10L)7,33120,392

Subscription demand

Amounts in ₹ crore. HNI subcategories are included in the NII total.

CategoryOfferedDemand
QIBs608.5218,123.87
RETAIL1,064.921,477.49
HNIs 2+152.13423.19
HNIs 10+304.261,856.37

Financial performance

Company financials

In Crores · Reported periods may include interim results.

Revenue & profitIn Crores
05001,0001,500Mar-22 · Revenue: 897Mar-22 · Profit after tax: 6Mar-22Mar-23 · Revenue: 1,245Mar-23 · Profit after tax: 9Mar-23Mar-24 · Revenue: 1,494Mar-24 · Profit after tax: 82Mar-24Sep-24 · Revenue: 693Sep-24 · Profit after tax: 28Sep-24
RevenueProfit after tax

Key performance indicators

MetricSep24Mar-24Mar-23
EPS1.494.530.55
ROE2.688.491.12
ROCE3.910.265.13
RONW2.688.51.13
Pre IPO0126.420
Post IPO0203.820

Values and labels as reported in the issue data.

Company information

Company profile

Sai Life Sciences Limited, incorporated in January 1999, specializes in researching, developing, and manufacturing small-molecule new chemical entities, serving over 280 innovator pharmaceutical companies in FY 2024, including more than 230 clients as of September 2024. Collaborating with 18 of the top 25 global pharmaceutical firms, the company provides services across the US, UK, Europe, and Japan, offering CMC/CDMO capabilities, integrated discovery through CRO services, and support in biology, chemistry, and pharmacokinetics. Supported by a workforce of 3,135 employees, including 2,353 scientific staff with 302 Ph.D.s and 1,475 master’s degrees, Sai Life Sciences drives innovation with a globally positioned business development team of 16 professionals.

Strengths

  • Integrated Platform: Offers end-to-end services from drug discovery to manufacturing.
  • Diverse Portfolio: Capable of managing molecules across early-stage and commercial phases.
  • Advanced Capabilities: Leverages cutting-edge technologies in biology, chemistry, and DMPK.

Risk factors

  • Customer Dependency: A significant portion of revenue comes from biotechnology and pharmaceutical clients, making the company vulnerable to industry-specific challenges, such as delays or failures in drug development and manufacturing.
  • Compliance Risks: Failure to meet customer standards during audits or inspections could damage reputation and potentially result in termination of contracts.
  • Market Uncertainties: Changes in customer demand, regulatory landscape, or industry trends may adversely affect business performance and growth prospects.

Promoters

Kanumuri Ranga Raju

Krishnam Raju Kanumuri

Kanumuri Mytrey

Sai Quest Syn Private Limited

Sunflower Partners

Lily Partners

Marigold Partners

Tulip Partners

Registrar & documents

Lead manager

Kotak Mahindra Capital Company, IIFL Capital Services Limited, Jefferies India Private Limited, Morgan Stanley India Company Private Limited

Registered office

Plot No. DS-7, IKP Knowledge Park, Turkapally Village, Shameerpet Mandal, Malkajgiri District, Hyderabad-500078

+9140 6815 6000

[email protected]Company website ↗

Frequently Asked Questions

What is Sai Life Sciences IPO GMP today?

As of today, Sai Life Sciences IPO Grey Market Premium (GMP) is reported at +₹71 per share. Based on the upper price band of ₹549, the estimated listing price is ₹620 (+12.9% expected listing gain). Please note that GMP is an unofficial market estimate for sentiment tracking and does not guarantee the actual listing price.

What is the lot size and minimum investment for Sai Life Sciences IPO?

The minimum bid lot size for Sai Life Sciences IPO is 27 shares. At the cut-off price of ₹549 per share, retail investors need a minimum application amount of ₹14,823 per lot. Retail applicants can apply for a maximum of 13 lots (up to ₹2,00,000).

When will Sai Life Sciences IPO allotment status be announced?

The allotment status for Sai Life Sciences IPO is scheduled to be finalized on 16 Dec 2024. If you applied for the IPO, you can verify whether shares have been allocated to your Demat account through Kfin Technologies Limited's official portal or via BSE/NSE allotment portals.

How can I check Sai Life Sciences IPO allotment status online by PAN?

To check Sai Life Sciences IPO allotment status: 1) Visit the registrar portal (Kfin Technologies Limited) or the BSE IPO allotment page. 2) Select 'Sai Life Sciences Limited' from the company dropdown. 3) Choose 'PAN' as your identification mode and enter your 10-digit Permanent Account Number. 4) Click 'Search' to view your allotted share quantity and application status.

Explore More IPO Analysis & Live Tools

Compare the price band and required investment with company financials and official offer documents. Grey market premium (GMP) figures are indicative market estimates collected from primary market brokers and do not establish the official listing price.

Regulatory Disclaimer: Grey Market Premium (GMP) is an unofficial, unregulated indicator of market sentiment and does not represent a stock exchange transaction, guarantee, or investment advice. IPO Premiums is an informational and research portal and is not a SEBI-registered investment advisor. Please consult a qualified financial advisor before applying for any IPO.
Sai Life Sciences IPO GMP Today, Subscription Status & Allotment Date | IPO Premiums